# CVE-2026-21980: Missing authorization in Oracle Life Sciences Central Coding

> Unauthenticated attackers can read and modify data in Oracle Life Sciences Central Coding via HTTP.

- **Severity:** Medium 6.5 (`CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N`)
- **Exploited in the wild:** Not known
- **Login needed:** Not needed
- **Attackable:** Over the internet
- **Victim action needed:** Not needed
- **Fix available:** No
- **Published:** 20 Jan 2026
- **Updated:** 21 Jan 2026
- **Also known as:** GHSA-xxf9-4c23-v3mw

## What is CVE-2026-21980?

CVE-2026-21980 is a medium-severity missing authorization vulnerability in Oracle Life Sciences Central Coding, published on 20 Jan 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.

### Official description

Vulnerability in the Oracle Life Sciences Central Coding product of Oracle Health Sciences Applications (component: Platform).   The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Coding.  Successful attacks of this vulnerability can result in  unauthorized update, insert or delete access to some of Oracle Life Sciences Central Coding accessible data as well as  unauthorized read access to a subset of Oracle Life Sciences Central Coding accessible data. CVSS 3.1 Base Score 6.5 (Confidentiality and Integrity impacts).  CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:N).

## Which versions are affected by CVE-2026-21980?

It affects 1 product.


Products: Oracle Life Sciences Central Coding.

## How do I fix CVE-2026-21980?

No fix has been published for CVE-2026-21980 yet. Limit exposure of the affected software until one is available.

## Is CVE-2026-21980 being exploited?

There is no known exploitation of CVE-2026-21980 in the wild and no public exploit code.

## Fix prompt for AI coding agents

```text
Check this codebase for CVE-2026-21980 and fix it if it is affected.

What it is: CVE-2026-21980 is a medium-severity missing authorization vulnerability in Oracle Life Sciences Central Coding, published on 20 Jan 2026. An attacker can exploit it over the internet without logging in, with no action from the victim.
Exploitation: There is no known exploitation of CVE-2026-21980 in the wild and no public exploit code.

Affected product: Oracle Life Sciences Central Coding. No package-level version data is available, so check the vendor advisory linked from the reference page.

Task:
1. Search the dependency manifests and lockfiles (for example package.json, package-lock.json, requirements.txt, poetry.lock, uv.lock, pom.xml, build.gradle, go.mod, Cargo.lock, Gemfile.lock) and any Dockerfiles for the affected packages, including transitive dependencies.
2. If an affected version is in use, upgrade it to the fixed version for its release line with the project's package manager, so the lockfile is regenerated. Prefer the smallest upgrade that fixes it.
3. If there is no fix, or the upgrade would break the build, do not guess: explain the risk and the safest workaround instead.
4. Run the tests and summarise what changed and why.
5. If nothing in the project is affected, say so and change nothing.

Reference: https://insights.sbomify.com/CVE-2026-21980/ (Markdown: https://insights.sbomify.com/CVE-2026-21980/index.md)
```

## Sources

- CVE record: https://www.cve.org/CVERecord?id=CVE-2026-21980
- NVD: https://nvd.nist.gov/vuln/detail/CVE-2026-21980
- OSV: https://osv.dev/vulnerability/CVE-2026-21980

---
From sbomify Insights: https://insights.sbomify.com/CVE-2026-21980/
Summaries are generated and may contain mistakes; the official description above is the record.